Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jamie Elvidge

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Pharmacoeconomics|October 12, 2021
Assessing Technologies for COVID-19: What are the Challenges for Health Technology Assessment Agencies? Findings From a Survey and Roundtable WorkshopJamie Elvidge, Dalia Dawoud
The Lancet. Digital Health|August 23, 2024
Reporting standards to support cost-effectiveness evaluations of AI-driven health careJamie Elvidge, Dalia Dawoud
Systematic Reviews|December 10, 2020
Challenges in synthesising cost-effectiveness estimatesGemma E Shields, Jamie Elvidge
Pharmacoeconomics|June 20, 2016
Cost Effectiveness of Characterised Chondrocyte Implantation for Treatment of Cartilage Defects of the Knee in the UKJamie Elvidge, Ash Bullement, Anthony J Hatswell
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 19, 2022
Diagnostics and Treatments of COVID-19: A Living Systematic Review of Economic EvaluationsJamie Elvidge, Ashley Summerfield, David Nicholls, et al.
BMJ Open|June 12, 2017
A systematic review of economic evaluations of seasonal influenza vaccination for the elderly population in the European UnionGemma E Shields, Jamie Elvidge, Linda M Davies
BMJ Evidence-Based Medicine|February 16, 2023
Living health technology assessments: how close to living reality?Grammati Sarri, Anna Forsythe, Jamie Elvidge, et al.
Frontiers in Pharmacology|June 1, 2022
A Review of Economic Models Submitted to NICE's Technology Appraisal Programme, for Treatments of T1DM & T2DMMarie-Josée Daly, Jamie Elvidge, Tracey Chantler, et al.
Frontiers in Pharmacology|November 30, 2023
Diagnostics and treatments of COVID-19: two-year update to a living systematic review of economic evaluationsJamie Elvidge, Gareth Hopkin, Nithin Narayanan, et al.
Frontiers in Pharmacology|September 11, 2023
Economic evaluations of artificial intelligence-based healthcare interventions: a systematic literature review of best practices in their conduct and reportingJai Vithlani, Claire Hawksworth, Jamie Elvidge, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Pharmacoeconomics|October 12, 2021
Assessing Technologies for COVID-19: What are the Challenges for Health Technology Assessment Agencies? Findings From a Survey and Roundtable WorkshopJamie Elvidge, Dalia Dawoud
The Lancet. Digital Health|August 23, 2024
Reporting standards to support cost-effectiveness evaluations of AI-driven health careJamie Elvidge, Dalia Dawoud
Systematic Reviews|December 10, 2020
Challenges in synthesising cost-effectiveness estimatesGemma E Shields, Jamie Elvidge
Pharmacoeconomics|June 20, 2016
Cost Effectiveness of Characterised Chondrocyte Implantation for Treatment of Cartilage Defects of the Knee in the UKJamie Elvidge, Ash Bullement, Anthony J Hatswell
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 19, 2022
Diagnostics and Treatments of COVID-19: A Living Systematic Review of Economic EvaluationsJamie Elvidge, Ashley Summerfield, David Nicholls, et al.
BMJ Open|June 12, 2017
A systematic review of economic evaluations of seasonal influenza vaccination for the elderly population in the European UnionGemma E Shields, Jamie Elvidge, Linda M Davies
BMJ Evidence-Based Medicine|February 16, 2023
Living health technology assessments: how close to living reality?Grammati Sarri, Anna Forsythe, Jamie Elvidge, et al.
Frontiers in Pharmacology|June 1, 2022
A Review of Economic Models Submitted to NICE's Technology Appraisal Programme, for Treatments of T1DM & T2DMMarie-Josée Daly, Jamie Elvidge, Tracey Chantler, et al.
Frontiers in Pharmacology|November 30, 2023
Diagnostics and treatments of COVID-19: two-year update to a living systematic review of economic evaluationsJamie Elvidge, Gareth Hopkin, Nithin Narayanan, et al.
Frontiers in Pharmacology|September 11, 2023
Economic evaluations of artificial intelligence-based healthcare interventions: a systematic literature review of best practices in their conduct and reportingJai Vithlani, Claire Hawksworth, Jamie Elvidge, et al.
Pageof 3